These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10147679)

  • 21. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isobutane driven salbutamol sulfate metered dose inhaler: formulation selection and respiratory tract absorption in guinea pigs].
    Ding L; Zhang JS
    Yao Xue Xue Bao; 2009 Sep; 44(9):1040-5. PubMed ID: 20055182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system.
    Ross DL; Gabrio BJ
    J Aerosol Med; 1999; 12(3):151-60. PubMed ID: 10623331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute neurobehavioral effects in rats from exposure to HFC 134a or CFC 12.
    Ritchie GD; Kimmel EC; Bowen LE; Reboulet JE; Rossi J
    Neurotoxicology; 2001 Apr; 22(2):233-48. PubMed ID: 11405255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solubility of solid solutes in HFA-134a with a correlation to physico-chemical properties.
    Hoye JA; Gupta A; Myrdal PB
    J Pharm Sci; 2008 Jan; 97(1):198-208. PubMed ID: 17828733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HS-GC-FID method for quantification of HFA-152a in cell culture media, and plasma from a range of species and regulatory compliant validations.
    Kuehl PJ; Corr S; Farrar J; McDonald JD; Wermer T; Weber D; Leach C
    J Pharmacol Toxicol Methods; 2023; 122():107271. PubMed ID: 37196729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of aerosol propellants in the respiratory and circulatory systems. VIII. Respiration and circulation in primates.
    Aviado DM; Smith DG
    Toxicology; 1975; 3(2):241-52. PubMed ID: 1124538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New apparatus and method for the toxicological investigation of metered aerosols in rats.
    Muacevic G
    Arch Toxicol; 1975 Sep; 34(1):1-8. PubMed ID: 127566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HFA-134a (1,1,1,2-tetrafluoroethane): effects of inhalation exposure upon reproductive performance, development and maturation of rats.
    Alexander DJ; Libretto SE; Adams MJ; Hughes EW; Bannerman M
    Hum Exp Toxicol; 1996 Jun; 15(6):508-17. PubMed ID: 8793535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ideal drug delivery system: a look into the future.
    Aiache JM
    J Aerosol Med; 1991; 4(4):323-34. PubMed ID: 10147683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity of aerosol propellants on the respiratory and circulatory systems. I. Cardiac arrhythmia in the mouse.
    Aviado DM; Belej MA
    Toxicology; 1974 Mar; 2(1):31-42. PubMed ID: 4823736
    [No Abstract]   [Full Text] [Related]  

  • 33. Subacute and chronic toxicity studies of fluorocarbon propellants in mice, rats and dogs.
    Smith JK; Case MT
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):438-43. PubMed ID: 4767579
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxicity of aerosol propellants in the respiratory and circularoty systems. X. Proposed classification.
    Aviado DM
    Toxicology; 1975; 3(3):321-32. PubMed ID: 804727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of aerosol propellants in the respiratory and circulatory systems. VII. Influence of pulmonary emphysema and anesthesia in the rat.
    Watanabe T; Aviado DM
    Toxicology; 1975; 3(2):225-40. PubMed ID: 235809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vivo disposition studies of 18F-labeled HFA-134a.
    Finch JR; Banks WR; Hwang DR; Satter MR; Ezzidene B; Mantil JC; Digenis GA
    Appl Radiat Isot; 1995 Apr; 46(4):241-8. PubMed ID: 7780376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. News Feature: How "forever chemicals" might impair the immune system.
    Beans C
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33833063
    [No Abstract]   [Full Text] [Related]  

  • 38. Resurgence of teen inhalant use.
    Chepesiuk R
    Environ Health Perspect; 2005 Dec; 113(12):A808. PubMed ID: 16330336
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolomics and cytotoxicity of monomethylhydrazine (MMH) and (E)-1,1,4,4-tetramethyl-2-tetrazene (TMTZ), two liquid propellants.
    Guyot L; Machon C; Honorat M; Manship B; Bouard C; Vigneron A; Puisieux A; Labarthe E; Jacob G; Dhenain A; Guitton J; Payen L
    Toxicol In Vitro; 2018 Oct; 52():70-86. PubMed ID: 29885439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference of anesthesia monitoring equipment by HFA propellants. Letter to the editor.
    Levin PD; Avidan A
    J Clin Monit Comput; 2010 Jun; 24(3):249. PubMed ID: 20532966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.